Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda’s Actoplus Met For Type 2 Diabetes Will Launch In October

Aug 30 2005

• By Andrew Shelton

Related Content

Takeda's Rozerem To Launch In September Following FDA Approval

Jul 22 2005

Paxil CR In Recovery, But Still Hobbling GSK’s U.S. Rx Sales Growth

Jul 28 2005

Takeda Files Actos/Metformin Combination Actoplus Met For Type 2 Diabetes

Oct 29 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window